A Factor Analytic Approach to Symptom Patterns in Dementia by Gustafson, Lars et al.
SAGE-Hindawi Access to Research
International Journal of Alzheimer’s Disease
Volume 2011, Article ID 632604, 11 pages
doi:10.4061/2011/632604
Research Article
AFactor AnalyticApproachto SymptomPatterns inDementia
LarsGustafson,1 CatarinaErikson,1 Siegbert Warkentin,1 Arne Brun,2
ElisabetEnglund,2 andUllaPassant1
1Department of Geriatric Psychiatry, Clinical Sciences, Lund, Lund University, 221 85 Lund, Sweden
2Department of Pathology, Clinical Sciences, Lund, Lund University, 221 85 Lund, Sweden
Correspondence should be addressed to Lars Gustafson, lars.gustafson@med.lu.se
Received 25 August 2010; Revised 9 November 2010; Accepted 10 December 2010
Academic Editor: Christiane Reitz
Copyright © 2011 Lars Gustafson et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Previous publications have shown a high diagnostic sensitivity and speciﬁcity of three short clinical rating scales for Alzheimer’s
disease (AD), frontotemporal dementia (FTD), and vascular dementia (VaD) validated against neuropathological (NP) diagnoses.
In this study, the aim was to perform an exploratory factor analysis of the items in these clinical rating scales. The study included
190 patients with postmortem diagnoses of AD (n = 74), VaD (n = 33), mixed AD/VaD (n = 31), or FTD (n = 52). The
factor analysis produced three strong factors. Factor 1 contained items describing cerebrovascular disease, similar to the Hachinski
Ischemic Score. Factor 2 enclosed major clinical characteristics of FTD, and factor 3 showed a striking similarity to the AD scale.
A fourth symptom cluster was described by perception and expression of emotions. The factor analyses strongly support the
construct validity of the diagnostic rating scales.
1.Introduction
Dementia is a clinical syndrome with a marked variety of
aetiology, clinical proﬁle, severity, and clinical course. The
diﬀerential diagnosis between various clinical and aetiolog-
ical subtypes may be diﬃcult, and so far no single diagnostic
approach or biomarker has fully solved these problems.
Few clinical symptoms and signs are pathognomonic of
dementia or a speciﬁc type of dementia. It is mostly the
symptom constellation, the timing of appearance, and the
clinical progression that lead to a diagnostic conclusion [1].
Apositivediagnosisofdementiaisoftenmadecomparatively
late in the disease process and for this reason most clinical
investigationsareperformedonpatientsinanadvancedstage
or retrospectively on patients with organic dementia deﬁned
postmortem.
Relevant to the present study, most factor analyses of
symptoms in dementia have been carried out for descriptive
purposes and less for the construction of diagnostic rating
scales.Aconventionalfactoranalysisof78symptomsinearly
onset dementia resulted in 14 clinically meaningful factors
[2]. Three factors contained symptoms of severe dementia,
three factors described mood changes or delusions, ﬁve
factors described personality changes and impaired con-
trol of emotional expressions, and three factors described
various motoric dysfunctions. The factors showed speciﬁc
relationships with regional Cerebral Blood Flow (rCBF)
and psychometric testing [2, 3]. In another study, factor
analysis of 16 symptoms of the Brief Psychiatric Rating Scale
(BPRS) in 87 geropsychiatric patients resulted in ﬁve clin-
ical dimensions: withdrawn depression, agitation, cognitive
dysfunction, hostile suspiciousness, and psychotic distortion
[4]. Petrovic et al. [5] identiﬁed four symptom clusters based
on factor analysis of the Neuropsychiatric Inventory (NPI)
in patients with dementia: psychosis, psychomotor, mood
liability,andinstinctualfactors.Anotherfactoranalysisoften
NPI items in probable AD resulted in three subsyndromes:
mood, psychotic, and frontal [6], and a factor analysis of the
12itemNPIshowedthepresenceoffourbehaviouralsubsyn-
dromes called hyperactivity, psychosis, aﬀective symptoms,
and apathy [7]. Thus, so far few factor analytic studies of
dementia symptoms have focused on diﬀerential diagnostic
issues. Bj¨ orkelund et al. presented a systematic review of
30 studies of the Organic Brain Syndrome (OBS) scale for
description of delirium and dementia [8]. Factor analysis of
the 53 clinical items of the OBS scale revealed three factors2 International Journal of Alzheimer’s Disease
describing diﬀerent types of disorientation and nine factors
describing diﬀerent cognitive and emotional disturbances,
and neurological symptoms.
Our previous publications from the Lund Longitudinal
Dementia Study have introduced two short diagnostic
rating scales, one for recognition of Alzheimer’s disease
(AD), the AD scale, and the other for diagnosis of primary
degenerative frontotemporal dementia (FTD), the FTD scale
[9]. Diﬀerential diagnostic screening with these two rating
scales and the Hachinski Ischemic Score (HIS) scale [10]h a s
been evaluated against postmortem neuropathological (NP)
diagnoses to analyze their feasibility for antemortem clinical
diagnosis of AD, vascular dementia (VaD), mixed AD/VaD,
and FTD [11]. The sensitivity and speciﬁcity of the AD scale
were 0.80 and 0.87, respectively, of the FTD scale 0.93 and
0.92, respectively, and of the HIS score (VaD diagnosis) 0.69
and 0.92, respectively. Cases with mixed AD/VaD generally
presented a combination of high AD and ischemic scores
[11]. However, no analysis of the individual items was
performed. Therefore, we present results from a principal
component factor analysis of the individual items of the
AD, FTD, and HIS scales (Table 5). The factor analyses
were used to identify clinical dimensions of dementia and
to conﬁrm the construct validity of the clinical rating scales.
Furthermore, the relationship between diﬀerent items and
NP diagnoses was studied as also the possibility to modify
and improve the clinical rating scales as diagnostic tools.
2.MaterialandMethods
This study was based on a prospective longitudinal clinical
work-up with a ﬁnal postmortem NP examination. The
study covers the time period from the late 1960s and
onwards and includes consecutive patients with symptoms
of dementia referred to the Psychogeriatric and Psychiatric
Departments of the University Hospital in Lund. The
patients and other informants were interviewed and the
neuropsychiatric symptoms and signs of the HIS, AD, and
FTD scales were evaluated and scored by a psychiatrist with
experience in the dementia ﬁeld. The 30 items and scores of
the three rating scales are presented in (Table 5). Exclusion
criteria were chronic psychosis and epilepsy, severe somatic
disease, severe head trauma, addiction, stroke with remain-
ing gross focal neurological symptoms, and conditions that
did not allow the application of the three clinical rating
scales. All patients fulﬁlled DSM III and ICD-10 criteria
for a dementia syndrome [12, 13]. The NP diagnoses were
based on standardized NP procedures and criteria recently
published [11]. The age characteristics and NP diagnoses are
shown in Table 1. The factor analytic study was based on
190 cases (77 male and 113 female) deceased in the years
1967–2007 with an NP diagnosis of AD, FTD, VaD, or mixed
AD/VaD and with a complete diagnostic scoring. Patients
with other NP diagnoses or incomplete scoring were not
included.
The average age at onset in the total material was 64.6
± 12.3 years (range 30–92 years) and diﬀered signiﬁcantly
between all the four major NP groups (ANOVA followed by
Student-Newman-Keulstest,Table 1).Themeanageatdeath
was 73.6 ± 11.35 years (range 34–97 years) with signiﬁcant
group diﬀerences, except between AD and VaD (74.7 and
76.5 years, resp.). The mean duration of illness was 8.9 ± 5.3
years (range 1–26 years). The mean duration was similar in
the AD and FTD groups (10.4 and 9.1 years, resp.). Only AD
corresponded with a signiﬁcantly longer duration compared
with VaD and mixed AD/VaD.
2.1. Diagnostic Rating Scales. The three diagnostic rating
scales, HIS scale, AD scale, and FTD scale, and their
thirty clinical items (Table 5) have been presented in a
previous publication as also the validation of the three
diagnostic scores against NP diagnoses [11]. The 30 items
were selected for the purpose of diﬀerential diagnosis of
dementia diseases. In this paper, the factor analysis was
performed of the diagnostic items scored in the 190 patients
with NP diagnoses.
2.2. Factor Analytic Approach. In order to detect clusters of
clinical symptoms and signs, the item scores were subjected
to conventional factor analysis using the principal compo-
nent method with varimax rotation [14]. Factor analysis is
a construct validity tool aiming at identifying underlying
clinical dimensions. The validity of a symptom cluster has
been deﬁned as the common variance of the factor and
the construct validity is studied by comparison with other
constructs[15].Factorswithaneigenvalueexceeding1.0and
an interpretable constellation of items are usually considered
of interest for the clinical description. The factor structure
willbedescribedbythesymptomswithfactorloadingsinthe
rotated factor matrix, which are considered as “signiﬁcant”
(at the 1% level), although there is no accepted standard
error of factor loadings [16]. Factor loadings of 0.30 or
greater are judged as signiﬁcant in most textbooks [17–19].
Thesimplestructureideaisfurthercorroboratedbyapattern
of zero factor loadings [20]. There are diﬀerent opinions
in terms of sample size in factor analysis. Hatcher [21]
recommended that the number of subjects should be ﬁve
times the number of variables, (which in this study means
150) or at least 100, while Hutcheson and Sofroniou [22]
recommended 150–300 subjects.
2.3. Statistical Analysis. Factor analysis was performed with
Stat View version 5.0.1. SAS Institute Inc. We performed
a principal component analysis of the 30 items included
in the rating scales, using an orthotran varimax procedure.
Factors with eigenvalues greater than 1.9 were selected in the
three-factorsolution.Factorloadingswithhighervalues(i.e.,
minimum 0.25) were included when they contributed to a
clinically meaningful interpretation pattern.
3. Results
There was a marked variation of the prevalence of diagnostic
scale items for the NP groups (Table 2).
Factor analysis of the 30 items scored in the 190 patients
resulted in several factors with eigenvalues exceeding 1.0. We
will ﬁrst present the three-factor solution with eigenvalues
of 5.2, 3.7, and 1.9 (Table 3) .A l lt h r e ef a c t o r sw e r ec l e a r l yInternational Journal of Alzheimer’s Disease 3
Table 1:Ageatonset,ageatdeath,durationofillness(mean ±SD(range)),andgendercharacteristicsin190patientswithneuropathological
dementia diagnosis.
(a)
NP diagnosis n (%) Male/Female Age at onset Age at death Duration of illness
(years) (years) (years)
AD 74 (35.4) 20/54 64.2 ± 10.2 74.7 ± 8.7 10.4 ± 4.9
(44–88) (59–93) (1–21)
FTD 52 (24.9) 23/29 54.7 ± 10.9 63.8 ± 11.5 9.1 ± 5.2
(30–84) (34–85) (1–26)
VaD 33 (15.8) 19/14 69.5 ± 9.9 76.5 ± 9.0 7.1 ± 6.4
(53–89) (58–93) (1–26)
Mixed AD/VaD 31 (14.8) 15/16 77.0 ± 6.5 84.3 ± 6.3 7.4 ± 4.0
(64–92) (71–97) (1–15)
Total 190 (100) 77/113 64.6 ± 12.3 73.6 ± 11.5 8.9 ± 5.3
(30–92) (34–97) (1–26)
(b)
Group comparisons (diﬀerence (95% CI)) Age at onset# Age at death## Duration of illness###
AD versus FTD 9.5 (5.7–13.3)∗ 10.9 (7.3–14.4)∗ 1.3 (−0.5–3.1)
AD versus VaD −5.2 (−9.5–−1.0)∗ −1.8 (−5.5–1.8) 3.3 (1.0–5.6)∗
AD versus mixed AD/VAD −12.7 (−16.7–−8.8)∗ −9.6 (−13.1–−6.2)∗ 2.9 (1.0–4.9)∗
FTD versus VaD −14.7 (−19.4–−10.1)∗ −12.7 (−17.4–−8.0)∗ 2.0 (−0.5–4.5)
FTD versus mixed AD/VaD −22.2 (−26.5–−17.9)∗ −20.5 (−25.0–−16.1)∗ 1.7 (−0.5–3.8)
VaD versus mixed AD/VaD −7.5 (−11.7–−3.3)∗ −7.8 (−11.7–−3.9) ∗ −0.4 (−3.0–2.3)
#ANOVA F3,184 = 36 (P < .001)
##ANOVA F3,186 = 34 (P < .001)
###ANOVA F3,184 = 4( P < .007)
∗Signiﬁcant diﬀerence (P < .05) Student-Newman-Keuls test.
interpretable and clinically relevant with several items with
strong factor loadings explaining 35.9% of the total variance.
Themajorityofitemswereunique,thatis,mainlycorrelating
to a single factor.
3.1. The Three-Factor Solution. The ﬁrst and strongest factor
was comprised of eight items with positive factor loadings
(0.47–0.75):“historyofstroke”,“stepwiseprogression”,“focal
neurological symptoms”, “abrupt onset”, “focal neurological
signs”, “evidence of associated arteriosclerosis”, “history of
hypertension”, and “ﬂuctuating course”. Furthermore, there
was one item, “slow progression” with a high negative factor
loading (−0.81) and four items with moderately negative
factor loadings (−0.25 to −0.43): “dyspraxia, dysphasia, and
dysgnosia”, “early loss of insight”, “early spatial disorienta-
tion”, and “early amnesia for remote events”. Thus factor 1
in several aspects agreed with the structure and scoring of
the HIS scale with the exception of “relative preservation of
personality” and “nocturnal confusion”.
Factor 2 (Table 3) included eight items with positive
factorloadings(0.26–0.67):“echolalia,latemutism,amimia”,
“early signs of disinhibition”, “early loss of insight”, “progres-
sive reduction of speech”, “Kl¨ uver-Bucy syndrome”, “stereo-
typy of speech”, “logorrhoea”, and “irritability, dysphoria”,
all of them present in the FTD scale. Four items showed
negative factor loadings: “relative preservation of person-
ality” (−0.47), “dyspraxia, dysphasia, dysgnosia” (−0.58),
“early spatial disorientation” (−0.72), and “early amnesia for
remote events” (−0.67). Thus the structure of the second
factor agrees with the symptom pattern described in the
original FTD scale with the exception of “confabulation”.
Finally, factor 3 (Table 3) contains eleven items with
positive factor loadings (0.27–0.63): “dyspraxia, dysphasia,
dysgnosia,” “epileptic seizures of late onset,” “increased
muscular tension,” “myoclonic twitchings,” “early spatial
disorientation,” “early amnesia for remote events,” “confab-
ulation,” “logoclonia,” “nocturnal confusion,” “irritability,
dysphoria,” and “emotional incontinence”. Seven of these
items belong to the AD scale. However, two other items,
“irritability-dysphoria” and “confabulation”, belong to the
FTD scale, and the two items “nocturnal confusion” and
“emotional incontinence” belong to the HIS scale. There was
no clinical item with an important negative factor loading in
factor 3.
The three-factor solution based on the clinical scoring of
190 patients with NP diagnosis of AD, VaD, mixed AD/VaD,
and FTD showed striking similarities to the three previously
established short clinical rating scales. Only two of the 30
items, “depression” and “somatic complaints”, did not show
any factor loading above 0.25 or below −0.25.4 International Journal of Alzheimer’s Disease
Table 2: Prevalence of clinical items (in percent) in four neuropathologically diagnosed dementia groups, AD (n = 74), FTD (n = 52),
VaD (n = 33), and mixed AD/VaD (n = 31).
AD FTD VaD Mixed AD/VaD
Slow progression 96 92 24 76
Early loss of insight 43 75 15 41
Early amnesia for remote events 77 8 15 66
Early spatial disorientation 77 2 21 72
Dyspraxia, dysphasia, dysgnosia (all symptoms present to some extent) 84 10 35 66
Logoclonia (stuttering-like speech disturbance) 14 2 0 7
Logorrhea (voluble speech) 81 50 7
Progressive reduction of speech 42 79 56 21
Epileptic seizure of late onset 23 6 12 17
Increased muscular tension 57 17 35 24
Myoclonic twitchings 19 0 0 14
Kl¨ uver-Bucy syndrome (hyperorality, hypersexuality, utilization behaviour) 83 79 4
Early signs of disinhibition 16 79 24 10
Irritability, dysphoria 37 52 35 41
Confabulation, spontaneous 32 14 24 31
Stereotypy of speech 32 50 0
Echolalia, late mutism, amimia (during the course) 10 56 3 0
Abrupt onset 10 2 74 21
Stepwise progression 4 6 74 38
Fluctuating course 27 6 79 66
Nocturnal confusion 26 4 15 28
Relative preservation of personality 41 2 62 28
Depression 18 37 44 14
Somatic complaints 27 31 47 31
Emotional incontinence 32 19 47 10
History of hypertension 15 8 65 31
History of stroke 12 4 77 45
Evidence of associated atherosclerosis 18 10 62 41
Focal neurological symptoms 10 14 74 31
Focal neurological signs 15 10 56 41
3.2. The Four-Factor Solution. To test the possibility of
additional clinical dimensions for the description and clas-
siﬁcation of dementia, a four-factor solution was also calcu-
lated. This resulted in four strong factors with eigenvalues
5.2, 3.7, 1.9, and 1.6, accounting for 41.2% of the unro-
tated and rotated clinical variance. Positive factor loadings
greater than 0.25 corresponding to P<. 01 are shown in
Table 4.
There were strong similarities between the ﬁrst three fac-
tors of the four-factor solution and the factors of the three-
factor solution. All four factors were interpretable as clini-
cally meaningful. The new fourth factor described an inter-
esting clinical dimension including ﬁve rather unique items
with positive factor loadings, “depression” (0.72), “somatic
complaints” (0.55), “emotional incontinence” (0.42), “irri-
tability, dysphoria” (0.40), and “progressive reduction ofInternational Journal of Alzheimer’s Disease 5
Table 3: A Three-factor analysis of 30 clinical items scored in 190 patients with a neuropathological diagnosis of AD, FTD, VaD, and mixed
AD/VaD. Factor loadings ≥+0.25 are in bold. Factor loadings ≤− 0.25 are set in italic.
Factor 1 Factor 2 Factor 3
History of stroke 0.70 −0.04 0.03
Stepwise progression 0.72 0.05 −0.07
Focal neurological symptoms 0.75 0.20 0.00
Abrupt onset 0.75 0.02 −0.03
Focal neurological signs 0.58 0.07 0.14
Evidence of associated atherosclerosis 0.49 −0.12 0.05
History of hypertension 0.47 −0.06 0.07
Fluctuating course 0.52 −0.21 −0.07
Depression 0.19 0.19 −0.18
Somatic complaints 0.16 −0.04 −0.09
Relative preservation of personality 0.12 −0.47 −0.13
Slow progression −0.81 −0.14 0.11
Echolalia, late mutism, amimia (during the course) −0.13 0.58 −0.05
Early signs of disinhibition 0.00 0.68 −0.17
Early loss of insight −0.25 0.40 0.16
Progressive reduction of speech 0.06 0.46 0.00
Kl¨ uver-Bucy syndrome (hyperorality, hypersexuality, utilization behaviour) −0.09 0.49 0.03
Stereotypy of speech −0.11 0.41 −0.11
Logorrhea (voluble speech) −0.13 0.27 0.11
Irritability, dysphoria 0.10 0.26 0.27
Dyspraxia, dysphasia, dysgnosia (all symptoms present to some extent) −0.30 −0.58 0.52
Epileptic seizure of late onset 0.00 0.03 0.60
Increased muscular tension 0.00 −0.09 0.58
Myoclonic twitchings −0.09 −0.04 0.63
Early spatial disorientation −0.32 −0.72 0.31
Early amnesia for remote events −0.43 −0.67 0.32
Confabulation, spontaneous −0.03 −0.06 0.35
Logoclonia (stuttering-like speech disturbance) −0.13 0.01 0.41
Nocturnal confusion 0.03 −0.17 0.39
Emotional incontinence 0.23 0.08 0.36
Eigenvalue 5.2 3.7 1.9
Variance % 17,3 12,2 6,46 International Journal of Alzheimer’s Disease
Table 4: A four-factor analysis of 30 clinical items scored in 190 patients with neuropathological diagnosis of VaD, AD, mixed AD/VaD and
FTD. Factor loadings ≥0.25 are in bold. Factor loadings ≤− 0.24 are set in italic.
Factor 1 Factor 2 Factor 3 Factor 4
Vascular Frontal Alz.type Mood
History of stroke 0.71 −0.04 0.02 −0.03
Stepwise progression 0.67 0.03 −0.07 0.14
Focal neurological symptoms 0.74 0.20 0.00 0.01
Abrupt onset 0.75 0.02 −0.04 −0.04
Focal neurological signs 0.64 0.09 0.12 −0.17
Evidence of associated atherosclerosis 0.49 −0.12 0.04 0.00
History of hypertension 0.48 −0.06 0.06 −0.03
Fluctuating course 0.49 −0.22 −0.07 0.08
Depression 0.04 0.11 −0.11 0.72
Somatic complaints 0.01 −0.10 −0.05 0.55
Relative preservation of personality 0.04 −0.49 −0.13 0.21
Slow progression −0.79 −0.13 0.11 −0.04
Echolalia, late mutism, amimia (during the course) −0.11 0.58 −0.03 −0.04
Early signs of disinhibition 0.00 0.68 −0.14 −0.01
Early loss of insight −0.18 0.42 0.16 −0.18
Progressive reduction of speech 0.01 0.44 0.04 0.25
Kl¨ uver-Bucy syndrome (hyperorality, hypersexuality, utilization behaviour) 0.13 0.48 0.06 0.16
Stereotypy of speech −0.07 0.42 −0.10 −0.09
Logorrhea (voluble speech) −0.02 0.30 0.10 −0.33
Irritability, dysphoria 0.00 0.22 0.31 0.40
Dyspraxia, dysphasia, dysgnosia (all symptoms present to some extent) −0.23 −0.56 0.48 −0.17
Epileptic seizure of late onset −0.00 0.03 0.62 0.11
Increased muscular tension 0.01 −0.09 0.59 0.10
Myoclonic twitchings 0.00 0.00 0.62 −0.19
Early spatial disorientation −0.31 −0.71 0.28 −0.04
Early amnesia for remote events −0.38 −0.65 0.29 −0.14
Confabulation, spontanteous 0.05 −0.03 0.34 −0.21
Logoclonia (stuttering-like speech disturbance) −0.10 0.02 0.41 −0.04
Nocturnal confusion 0.02 −0.17 0.39 0.06
Emotional incontinence 0.12 0.05 0.39 0.42
Eigenvalue 5.2 3.7 1.9 1.6
Variance % 17.3 12.2 6.4 5.3International Journal of Alzheimer’s Disease 7
Table 5: Rating scales for diﬀerential diagnosis of dementia.
Alzheimer’s disease scale Frontotemporal dementia scale Hachinski Ischemic Score, HIS
Symptom/item Score Symptom/item Score Symptom/item Score
Slow progression 1 Slow progression 1 Abrupt onset 2
Early loss of insight 1 Early loss of insight 2 Stepwise progression 1
Early amnesia for remote events 2 Early signs of disinhibition 2 Fluctuating course 2
Early spatial disorientation Irritability, dysphoria 1 Nocturnal confusion 1
(impaired sense of locality) 2 Confabulation spontaneous 1 Relative preservation of personality 1
Dyspraxia, dysphasia, dysgnosia, (all Logorrhea, (voluble speech) 1 Depression 1
symptoms present to some extent) 2 Progressive reduction of speech 1 Somatic complaints 1
Logoclonia, (stuttering-like speech Stereotypy of speech 1 Emotional incontinence 1
disturbance) 2 Echolalia, late mutism, amimia, (at History of hypertension 1
Logorrhoea, (voluble speech) 1 least two of three symptoms during the History of strokes 2
Progressive reduction of speech 1 course) 2 Evidence of associated
Epileptic seizure of late onset 1 Kl¨ uver-Bucy syndrome, atherosclerosis 1
Increased muscular tension 2 (hyperorality, hypersexuality Focal neurological symptoms 2
Myoclonic twitchings 1 utilization behaviour) 1 Focal neurological signs 2
Kl¨ uver-Bucy syndrome, (hyperorality,
hypersexuality, utilization behaviour) 1
Total score Total score Total score
Max score 17 Max score 13 Max score 18
speech”(0.25).Togethertheseﬁveitemshighlighttheclinical
importance of a symptom pattern described by emotional
feelings and expressions (Figure 1).
Figure 1 shows the mean number of patients (in percent)
within each diagnostic group, scoring on each individual
item within the respective factor. The vascular, frontal, and
Alzheimer type factors showed speciﬁc relationship to the
respective NP diagnoses, while the symptoms of the mood
factor were found in all four NP groups.
4. Discussion
In an earlier publication from our prospective longitudinal
study of dementia conditions, three diagnostic rating scales
withthirtyclinicalitemswerevalidatedagainstNPdiagnoses
of dementia. The results showed satisfactory speciﬁcity and
sensitivity of the rating scales for diagnosis of AD, FTD,
VaD, and mixed AD/VaD. The aim of the present study
was to further elucidate the structure of the rating scales
by factor analysis of the clinical items that were used in
the diagnostic process. The scoring was based on direct
observations as well as on information from the patient
and other informants. This information is also crucial for
estimation of the patients’ premorbid personality, emotional
behaviour, social competence, cognitive proﬁle, education,
and clinical changes over time. There are limitations but
Vascular
factor
Frontal
factor
Alz. type
factor
Mood
factor
0
10
20
30
40
50
60
70
80
VaD
FTD
AD
Mixed AD/VaD
Figure 1: The X-axis depicts the individual factors obtained in the
4-factor analysis presented in Table 4. The points in the graph show
the mean number of patients (in percent) within each diagnostic
group, scoring on each individual item within the respective factor.8 International Journal of Alzheimer’s Disease
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also advantages of the long-term design of this study. There
might be certain diﬃculties to standardize the diagnostic
process, both the clinical and the histopathological aspects.
In ﬁfteen items, the evaluation was based on the patient’s
medical history as well as on clinical observations. Twelve
items relied on history mainly, and for three items (increased
musculartension,evidenceofassociatedarteriosclerosis,and
focal neurological signs) the scoring was almost exclusively
based on observations.
An additional limitation to be considered is the sample
size. The 190 cases were considered representative of patients
referred for clinical examination and diagnosis of dementia
disease [11]. The mean age at onset was fairly low probably
due to the comparatively large number of FTD cases.
Moreover, there was a wide range of the disease duration
compared to other studies of postmortem veriﬁed dementia.
During the time span of the NP examinations in the present
study, the procedures and the classiﬁcation of dementia
have developed and changed. The advent of immuno-
histochemistry in the 1980–90 supplemented the basic
neuropathological observations made during the 20 years
antedating the mentioned histotechnical advances. Basically
these innovations conﬁrmed the originally observed changes
rather than adding new features. Still, however, AD, VaD,
mixed AD/VaD, and FTD have been the predominant NP
diagnoses similar to those in other large studies [23].
Patients with AD pathology probably include cases with
additional histopathological presence of dementia with Lewy
bodies.
The clinical dimensions were attained and studied with
conventional factor analysis. We are contented with the
ﬁrst three factors with high eigenvalues and meaningful
clinical constructs based on unique items and “signiﬁcant”
factor loadings. Factor 1 with a strong similarity to the
original HIS contained items describing risk factors, clinical
course, symptoms, and signs associated with cerebrovascular
disease [24]. Factor 2 presented a cluster of clinical features
associated with brain dysfunction predominantly involving
frontal and frontotemporal brain areas. It has a striking
similarity to the consensus on clinical criteria for FTD [25]
andfrontotemporallobardegeneration(FTLD)[26].Finally,
thethirdfactorcontainedcognitive,executive,andneurolog-
ical symptoms related to hippocampal, temporoparietal, and
subcortical structures often involved in AD. Although none
of these symptoms are unique for AD, they may strongly
contribute to the diagnostic reliability, when appearing
in a speciﬁc constellation. The factor analyses strongly
support the construct validity of the three diagnostic rat-
ing scales. Finally the factor analysis also revealed a new
symptom cluster characterised by perception and expression
of emotions. The rating scales and the factor solutions
are recommended for clinical as well as research centre
settings.
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